TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioInvent International AB
Closing information (x1000 EUR)
| Closing information | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Turnover |
6,440
|
29,306
|
1,895 |
| Financial expenses |
138
|
71
|
70 |
| Earnings before taxes |
-29,749
|
-3,819
|
-27,227 |
| EBITDA |
-33,340
|
-4,576
|
-27,217 |
| Total assets |
126,188
|
153,861
|
141,520 |
| Current assets |
102,133
|
97,415
|
109,126 |
| Current liabilities |
6,842
|
7,847
|
5,749 |
| Equity capital |
118,036
|
144,328
|
133,666 |
| - share capital |
1,186
|
1,168
|
1,143 |
| Employees (average) |
104
|
89
|
79 |
Financial ratios
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Solvency |
93.5%
|
93.8%
|
94.5% |
| Turnover per employee |
62
|
329
|
24 |
| Profit as a percentage of turnover |
-461.9%
|
-13.0%
|
-1436.8% |
| Return on assets (ROA) |
-23.5%
|
-2.4%
|
-19.2% |
| Current ratio |
1492.7%
|
1241.4%
|
1898.2% |
| Return on equity (ROE) |
-25.2%
|
-2.6%
|
-20.4% |
| Change turnover |
-22,951
|
27,564
|
-12,515 |
| Change turnover % |
-78%
|
1582%
|
-87% |
| Chg. No. of employees |
15
|
10
|
7 |
| Chg. No. of employees % |
17%
|
13%
|
10% |
Total value of public sale
| Fiscal year | 2023/12 (consolidated) | 2022/12 (consolidated) | 2021/12 (consolidated) |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.